AstraZeneca stock heads into the open after a 1.20 percent drop

At the close on September 23, 2026, AstraZeneca stock stood at 12,512.00 GBX after falling 1.20 percent on the London Stock Exchange. The FTSE 100 was up 0.07 percent at 10,715.47 during the session.

AstraZeneca stock closed at 12,512.00 GBX on the London Stock Exchange on September 23, 2026, down 1.20 percent. The shares underperformed the FTSE 100, which was quoted at 10,715.47, up 0.07 percent, in the same session.

September 23, 2026 in numbers

AstraZeneca plc (ISIN GB0009895292) traded at 12,512.00 GBX at the close on September 23, 2026. The session change was negative 1.20 percent, while the FTSE 100 recorded a 0.07 percent gain during the same London session.

The company announced on September 23, 2026, that the European Commission approved Trixeo as a maintenance treatment for asthma in patients aged 12 years and older, as Newsquawk reported. A separate market report quoted AstraZeneca at 12,512.00 GBX and down 1.20 percent on September 23, 2026.

Trixeo approval remains dated today

The Trixeo approval is the company-specific event dated September 23, 2026. It expands the approved asthma use to patients aged 12 years and older in the European Union, according to GuruFocus.